Ebola in DR Congo: The Outbreak Just Became the Deadliest in the Country's History
-- reading | Updated:
The World Health Organization called an emergency meeting for today — because someone in DR Congo is now dying of Ebola every 30 minutes.
2,325 deaths as of Aug 16, 2026 — the deadliest Ebola outbreak in the country's history.
Yes — with 4,686 confirmed cases and 2,325 deaths as of Aug 16, this is officially the largest and deadliest Ebola outbreak ever recorded in DR Congo, and the WHO's emergency committee meets today, Aug 18.
The numbers keep climbing in DR Congo's Ebola crisis, declared a Public Health Emergency of International Concern (PHEIC) since May 17. The 2026 outbreak is now bigger than the 2018–2020 North Kivu epidemic (3,317 cases) that held the record for six years — and unlike that one, it's still accelerating.
Why This Outbreak Is Different From Every Other
This is a Bundibugyo species of Ebola — not the Zaire species behind most past outbreaks — spreading across 54 health zones in 6 provinces. As of Aug 12, official numbers showed 4,686 confirmed cases, 2,186 deaths and a case fatality rate of 46.8%. By Aug 16, Reuters reported the death toll had reached 2,325, with more than 300 children among the victims. The WHO warned on Aug 14 that the virus is "winning," killing roughly one person every 30 minutes, as cases double faster than any previous outbreak.
The Twist: It's Not Spreading the Way You Think
Ebola is spreading mainly through health care settings and household transmission — not flights and airports. There have been 12 attacks on health care workers and facilities, forcing clinics to close in outbreak zones. Yet the WHO still advises against travel or trade restrictions: Uganda declared its own outbreak over on July 28 (20 cases, 2 deaths), and the handful of international cases — 1 in France, 2 treated in Germany — were contained and linked to direct exposure in the region.
What Today's Emergency Meeting Could Change
The WHO's IHR Emergency Committee convenes Aug 18 to decide whether new measures are needed. Behind the scenes, the response relies on the Ervebo vaccine and obeldesivir, an experimental oral antiviral in trials — but funding is the weak point: the response plan needs $518 million. For travelers and Americans, the practical risk remains low, but the committee's decision today could reshape how the world watches this outbreak.
